Internal Medicine, Cardiovascular Disease · Largo, MD
NPI
1720070261
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1450 Mercantile Ln, Suite 217
Largo, MD, 20774
Phone (301) 583-7770
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
1,071 services
Medicare patients, 2024
224
Average age 77
Drug cost, 2024
$1.3M
4,268 prescriptions
Company payments, 2025
$19K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Gooray was code 99214 (office e&m - established), 565 times for 215 patients. In total David A Gooray billed 1,071 services in 11 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 565 | 215 | $95.86 | $54K |
| 93306 Echocardiography (TTE/TEE) | Office | 210 | 166 | $156.65 | $33K |
| 93000 Electrocardiogram | Office | 136 | 119 | $9.76 | $1,327 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 62 | 54 | $158.56 | $9,831 |
| 99213 Office E&M - Established | Office | 50 | 46 | $69.30 | $3,465 |
| 99215 Office E&M - Established | Office | 22 | 17 | $128.43 | $2,825 |
| 99204 Office E&M - New | Office | 11 | 11 | $125.08 | $1,376 |
By year: 2022 $127K for 1,121 services; 2023 $140K for 1,252 services; 2024 $106K for 1,071 services.
Medicare prescription drug claims, 2024
In 2024, the drug David A Gooray prescribed most often to Medicare patients was Rosuvastatin Calcium, with 334 prescriptions and refills. In total David A Gooray wrote 4,268 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 334 | 977 | 116 | $7,588 |
| Carvedilol Generic | 295 | 842 | 85 | $3,286 |
| Entresto Sacubitril/Valsartan | 226 | 433 | 56 | $285K |
| Jardiance Empagliflozin | 217 | 391 | 57 | $217K |
| Eliquis Apixaban | 160 | 307 | 38 | $173K |
| Nifedipine Er Nifedipine | 157 | 402 | 47 | $4,756 |
| Telmisartan Generic | 137 | 376 | 44 | $5,034 |
| Clopidogrel Clopidogrel Bisulfate | 109 | 311 | 40 | $1,390 |
| Spironolactone Generic | 109 | 319 | 44 | $1,526 |
| Nebivolol Hcl Generic | 91 | 262 | 32 | $6,284 |
| Losartan Potassium Generic | 89 | 258 | 33 | $1,060 |
| Metoprolol Succinate Generic | 78 | 228 | 28 | $2,225 |
| Pravastatin Sodium Generic | 71 | 216 | 23 | $1,701 |
| Perindopril Erbumine Generic | 63 | 181 | 18 | $4,429 |
| Ozempic Semaglutide | 61 | 111 | 18 | $105K |
Brand drugs: - claims; generic drugs: 3,155 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A Gooray $19K ($19K in general payments such as food, travel and fees) from 14 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $9,834.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 22 | $9,834 |
| Lilly USA, LLC LLY | 5 | $5,720 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $2,941 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $307 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $137 |
| BridgeBio Pharma, Inc. BBIO | 1 | $109 |
| Scpharmaceuticals Inc. SCPH | 4 | $106 |
| Merck Sharp & Dohme LLC MRK | 4 | $90.42 |
| Pfizer Inc. PFE | 3 | $66.57 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $56.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.